We are headquartered at the Empire State Building in New York City and are investigating Entero Therapeutics, Inc. (NASDAQ: ENTO), relating to the proposed merger with Journey Therapeutics, Inc. Under ...

Entero Therapeutics (ENTO) has entered into a binding term sheet for a reverse merger transaction with Journey Therapeutics. Upon completion of ...

Ademi LLP is investigating Entero (Nasdaq: ENTO) for possible breaches of fiduciary duty and other violations of law in its transaction with Journey . Click here to learn how to join our investigation ...

Accumulated cases of serious flu complications and flu-related deaths have hit a decade high this flu season, the Centers for Disease Control (CDC) said yesterday, as it reported 20,913 hospital ...

In the wake of a historic U.S. election, global markets have shown robust performance, with major indices like the S&P 500 and Nasdaq Composite reaching record highs amid expectations of favorable ...

Trump's victories in the Rio Grande Valley starkly showed how working-class voters nationwide are shifting toward Republicans ...